Filing Details
- Accession Number:
- 0001127602-13-035694
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-27 17:41:31
- Reporting Period:
- 2013-12-26
- Filing Date:
- 2013-12-27
- Accepted Time:
- 2013-12-27 17:41:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236440 | E Floyd Bloom | Connaught House 1 Burlington Road Dublin 4 Ireland | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2013-12-26 | 20,000 | $40.97 | 110,281 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.665 to $41.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.